These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 6324818

  • 21. Cyclic nucleotide phosphodiesterase in rat neostriatum: multiple isoelectric forms with similar kinetic properties.
    Minneman KP.
    J Neurochem; 1976 Nov; 27(5):1181-9. PubMed ID: 12170605
    [Abstract] [Full Text] [Related]

  • 22. Isolation of similar rolipram-inhibitable cyclic-AMP-specific phosphodiesterases from rat brain and heart.
    Némoz G, Moueqqit M, Prigent AF, Pacheco H.
    Eur J Biochem; 1989 Oct 01; 184(3):511-20. PubMed ID: 2553394
    [Abstract] [Full Text] [Related]

  • 23. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
    Marcoz P, Prigent AF, Lagarde M, Nemoz G.
    Mol Pharmacol; 1993 Nov 01; 44(5):1027-35. PubMed ID: 8246905
    [Abstract] [Full Text] [Related]

  • 24. [Pharmacologic value of cyclic nucleotide phosphodiesterase inhibitors].
    Nemoz G, Prigent AF.
    Ann Pharm Fr; 1984 Nov 01; 42(2):99-112. PubMed ID: 6091520
    [No Abstract] [Full Text] [Related]

  • 25. Actions of papaverine on intestinal smooth muscle and its inhibition of cyclic AMP and cyclic GMP phosphodiesterases.
    Miyamoto M, Takayanagi I, Ohkubo H, Takagi K.
    Jpn J Pharmacol; 1976 Feb 01; (1):114-7. PubMed ID: 177797
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Effects of phosphodiesterase inhibitors, imidazole and phosphate on cyclic CMP phosphodiesterase are different from those on cyclic AMP and cyclic GMP phosphodiesterases.
    Kuo JF, Shoji M, Brackett NL, Helfman DM.
    J Cyclic Nucleotide Res; 1978 Dec 01; 4(6):463-74. PubMed ID: 85641
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Potent tetracyclic guanine inhibitors of PDE1 and PDE5 cyclic guanosine monophosphate phosphodiesterases with oral antihypertensive activity.
    Ahn HS, Bercovici A, Boykow G, Bronnenkant A, Chackalamannil S, Chow J, Cleven R, Cook J, Czarniecki M, Domalski C, Fawzi A, Green M, Gündes A, Ho G, Laudicina M, Lindo N, Ma K, Manna M, McKittrick B, Mirzai B, Nechuta T, Neustadt B, Puchalski C, Pula K, Zhang H.
    J Med Chem; 1997 Jul 04; 40(14):2196-210. PubMed ID: 9216839
    [Abstract] [Full Text] [Related]

  • 32. Multiple actions of glaucine on cyclic nucleotide phosphodiesterases, alpha 1-adrenoceptor and benzothiazepine binding site at the calcium channel.
    Ivorra MD, Lugnier C, Schott C, Catret M, Noguera MA, Anselmi E, D'Ocon P.
    Br J Pharmacol; 1992 Jun 04; 106(2):387-94. PubMed ID: 1327380
    [Abstract] [Full Text] [Related]

  • 33. Selective inhibition of separated forms of cyclic nucleotide phosphodiesterase from rat heart by some cardio- or vaso-active butenolide derivatives.
    Némoz G, Prigent AF, Picq M, Pacheco H.
    Biochem Pharmacol; 1982 Nov 01; 31(21):3353-8. PubMed ID: 6293510
    [No Abstract] [Full Text] [Related]

  • 34. Y-590 (a new pyridazinone derivative), a potent anti-thrombotic agent--II. Inhibition of platelet phosphodiesterase.
    Mikashima H, Nakao T, Goto K, Ochi H, Yasuda H, Tsumagari T.
    Thromb Res; 1984 Sep 01; 35(5):589-94. PubMed ID: 6091293
    [Abstract] [Full Text] [Related]

  • 35. Differential effects of cyclic nucleotides and their analogs and various agents on cyclic GMP-specific and cyclic AMP-specific phosphodiesterases purified from guinea pig lung.
    Davis CW, Kuo JF.
    Biochem Pharmacol; 1978 Jan 01; 27(1):89-95. PubMed ID: 202285
    [No Abstract] [Full Text] [Related]

  • 36. Different sensitivites of cyclic nucleotide phosphodiesterases of rat brain and lung to inhibition by new anti-allergic chromones [proceedings].
    Saeed SA, Butt NM, Spicer JW, Warren BT.
    Biochem Soc Trans; 1979 Dec 01; 7(6):1308-10. PubMed ID: 231533
    [No Abstract] [Full Text] [Related]

  • 37. Selective inhibition of separated forms of cyclic nucleotide phosphodiesterase from rat heart by some pentasubstituted quercetin analogs.
    Picq M, Prigent AF, Nemoz G, Pacheco H.
    Biochem Pharmacol; 1982 Sep 01; 31(17):2777-82. PubMed ID: 6291544
    [Abstract] [Full Text] [Related]

  • 38. Cyclic nucleotide phosphodiesterases from rat anterior pituitary. Characterization of multiple forms and regulation by protein activator and Ca+.
    Azhar S, Menon KM.
    Eur J Biochem; 1977 Feb 15; 73(1):73-82. PubMed ID: 190011
    [Abstract] [Full Text] [Related]

  • 39. Cyclic 3',5'-AMP phosphodiesterase of rabbit aorta.
    Hidaka H, Asano T, Shimamoto T.
    Biochim Biophys Acta; 1975 Jan 23; 377(1):103-16. PubMed ID: 164219
    [Abstract] [Full Text] [Related]

  • 40. Phosphodiesterase inhibitors: their comparative effectiveness in vitro in various organs.
    Adachi K, Numano F.
    Jpn J Pharmacol; 1977 Feb 23; 27(1):97-103. PubMed ID: 194077
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.